THE STUDY OF ASSOCIATION OF TYPE 2 DIABETES MELLITUS AND TINEA PEDIS : A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/g4b9cb13Keywords:
Diabetes mellitus, tinea pedisAbstract
Background: A common fungal infection that is more common in those with weakened immune systems is tinea pedis. people with diabetes continue to be more prone to tinea pedis than other people because of their compromised vascular and immune systems.
Aims : This systematic review is to review the association of type 2 diabetes mellitus and cases of tinea pedis.
Methods: This study demonstrated compliance with all requirements by means of a comparison with the standards established by the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020. Thus, the specialists were able to guarantee that the research was as current as feasible. Publications released between 2014 and 2024 were considered for this search strategy. This was accomplished by utilizing a number of distinct online reference sites, including Pubmed, ScienceDirect, and SagePub. It was determined that reviews, previously published works, and partially completed works would not be included.
Result: In the PubMed database, the results of our search brought up 68 articles, whereas the results of our search on SCIENCE DIRECT brought up 885articles, our search on SAGEPUB brought up 65 articles. The results of the search conducted for the last year of 2014 yielded a total 24 articles for PubMed, 316 articles for SCIENCE DIRECT and 18 articles for SAGEPUB. In the end, we compiled a total of 8 papers, 6 of which came from PubMed, 1 of which came from SCIENCE DIRECT and 1 of which came from SAGEPUB. We included eight research that met the criteria.
Conclusion: In summary, there are association between the cases of tinea pedis in patients with diabetes mellitus.
References
Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus M. 1994;30(4):519–31.
Almind K, Doria A, Kahn CR. Putting the genes for type II diabetes on the map. 2001;277–9.
Rewers M, Norris JM, Eisenbarth GS, Erlich HA, Beaty B, Klingensmith G. Beta-Cell Autoantibodies in Infants and Toddlers without IDDM Relatives: Diabetes Autoimmunity Study in the Young (DAISY). J Autoimmun. 1996;9(3):405–10.
Kovitwanichkanont T, Chong AH. Superficial fungal infections. Aust J Gen Pract. 2019;48(10):706–11.
Sahoo A, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatol Online J. 2016;7(2):77.
Schlefman BS. Onychomycosis: A compendium of facts and a clinical experience. Journal of Foots Ankle Surgery. 1999;38(4):290–302.
Gupta AK, cahow M, Daniel CR, Aly R. Treatments of tinea pedis. Dermatol Clin. 2003;21(3):431–62.
Bristow IR, Spruce MC. Fungal foot infection, cellulitis and diabetes: a review. Wiley. 2009;26(5):548–51.
Thomas J, Jacobson GA, Narkowicz CK. Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther. 2010;497–519.
Chen B, Mitchell A, Tran D. “Step up for foot care”: addressing podiatric care needs in a sample homeless population. J Am Podiatr Med Assoc. 2014;104(3):269–76.
Kuhnke JL, Keast DH, Evans R. Education, Research Barriers and Solutions to the Implementation of Best Practice in Diabetes-related Foot Care, Footwear and Wound Care: A Qualitative Inquiry. Limb Preservation Journal. 2023;10–21.
Aragon-Sanchez J, Lopez-Valverde ME, Viquez-Molina G, Milagro-Beamonte A, Torres-Sopena L. Onychomycosis and Tinea Pedis in the Feet of Patients With Diabetes. Int J Low Extrem Wounds. 2023;22(2):321–7.
Khalifa A, Alreshidi IG, Alaradi LA, Alrashidi YM. Tinea Unguium and Tinea Pedis and Their Correlation With Diabetes Mellitus in the General Population in the Hail Region, Saudi Arabia: A Cross-Sectional Study. Cureus. 2023 Jun 8;
Akkus G, Evran M, Gungor D, Karakas M, Sert M, Tetiker T. Tinea pedis and onychomycosis frequency in diabetes mellitus patients and diabetic foot ulcers: A cross sectional - Observational study. Pak J Med Sci. 2016 Jul 1;32(4).
Oz Y, Qoraan I, Oz A, Balta I. Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey. Int J Dermatol. 2017;56(1):68–74.
Alhammadi N, Al-Jallal M, AlKaabi HA, Malibari WM, Al Jallal RS, Almarshad AS, et al. Prevalence and Factors Associated With Tinea Pedis Among Diabetic Patients in Saudi Arabia: A Descriptive Cross-Sectional Study. Cureus. 2023;15(12).
Henry D. A study of pattern of cutaneous manifestations in patients with diabetes mellitus. Vol. 30, Journal of Pakistan Association of Dermatologists. 2020.
Alqahtani S, Qowaider S, Hamad M, Ali M. Microbiological Profile and Antimicrobial Susceptibility Patterns in Patients with Tinea Pedis at Diabetic Center In EL-Beyda City. AlQalam Journal of Medical and Applied Sciences. 2024 Mar 31;50–5.
Nijenhuis-Rosien L, leefstra N, van Dijk PR, Wolfhagen MJHM, roenier KH, Bilo HJ, et al. Laser therapy for onychomycosis in patients with diabetes at risk for foot ulcers: a randomized, quadruple-blind, sham-controlled trial (LASER-1). J Eur Acad Dermatol Venereol. 2019;33(11):2143–50.
Kumar A, Jain C, Diab D, Diab F. Type 1 diabetic foot complications Open access publishing The Journal of Diabetic Foot Complications Type 1 diabetic foot complications [Internet]. Vol. 8, The Journal of Diabetic Foot Complications. 2016. Available from: https://www.researchgate.net/publication/328282372
Nigam PK, Syed HA, Saleh D. Tinea Pedis. StatPearls. 2023;
Al-Ani YMM. STUDY OF TINEA PEDIS IN DIABETIC VERSUS NON-DIABETIC PATIENTS. Al Kindy College Medical Journal. 2020;
Toukabri N, Dhieb C, Euch DE, Rouissi M, Mokni M, Sadfi-Zouaoui N. Prevalence, Etiology, and Risk Factors of Tinea Pedis and Tinea Unguium in Tunisia. Can J Infect Dis Med Microbiol. 2017;
Ilkit M, Durdu M. Tinea pedis: the etiology and global epidemiology of a common fungal infection. Crit Rev Microbiol. 2015;41(3):374–88.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Novitafalen, Nathania Christika, Henyta, Ririn Azhari, Astrid Ananda, Afdila Syarfina
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
